NCT00590694View on ClinicalTrials.gov

Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Age-related Macular DegenerationPigment Epithelial DetachmentNeovascular Macular DegenerationWet Macular Degeneration
Interventions
DRUG

ranibizumab

0.5mg injection monthly according to protocol for one year

Trial Locations (1)

94115

Pacific Eye Associates, San Francisco

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Pacific Eye Associates

OTHER

NCT00590694 - Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments | Biotech Hunter | Biotech Hunter